• US Nuclear Strikes Back Against Degradation of America’s Fisheries Seacoasts and Harbors

    US Nuclear Strikes Back Against Degradation of America’s Fisheries Seacoasts and Harbors

    Los Angeles, CA. August 27, 2019 – US Nuclear’s (OTC: UCLE) unique line of products already includes drones, air and stack monitors, water quality monitors, and even food monitors for measuring on-site industrial pollution, including harmful chemicals, bio-hazards, and radioactive toxins. Due to increasing demand, US Nuclear is now adding an industrial underwater robotic product line that features chemical, biological, and radiological sensors for constant, real-time water monitoring. These underwater robots would be deployed where they are needed most including seaports, reservoirs, water treatment plants, hatcheries, and wildlife preserves, and environmentally sensitive areas. Robert Goldstein, CEO of US Nuclear, commented “Every day we read about the degradation and loss of marine plants and animals in addition to the human sickness caused by contaminants and pollution. With these additions, we now offer a product that can efficiently monitor these pollutants continuously and in real-time so we can act quickly to mitigate the pollution.”

    Building on the success of the DroneRAD platform (UAVs mounted with CBRN sensors), US Nuclear recently teamed up with QYSEA Technology to design and build new industrial underwater robots integrated with radiological, chemical, biological, and video sensors. Backed by new knowledge and experience in the unmanned vehicle market, US Nuclear is continuing to design and build new sensor packages for the QYSEA platform to meet new mission objectives and requirements from customers. Unmanned underwater vehicles have many advantages over traditional methods used for measuring hazardous pollution, including continuous and real-time measurement with little to no downtime, more efficient, safer, cheaper, and less time-consuming. US Nuclear’s strategy is to deploy these real-time underwater robotic systems to safeguard vital locations which require constant monitoring of harmful pollutants, such as seaports, water treatment plants, and environmentally sensitive areas such as coral reefs.

    (more…)

  • US Nuclear Uplifted to OTC-QB Market

    US Nuclear Uplifted to OTC-QB Market

    Los Angeles, CA. July 29, 2019 – The continued growth of US Nuclear Corp (OTC: UCLE) has led the company to upgrade to the OTC-QB market.  US Nuclear Corp was previously listed on the OTC-Pink Marketplace, and this upgrade will help the company build shareholder value, increase visibility, and engage new investors.

    The key benefits of upgrading to OTC-QB include:

    Better Information: OTC-QB is recognized by the SEC as an established public market.  The platform enables US Nuclear to provide current public information that investors need to analyze, value, and trade UCLE.

    Efficient Market Standards: Multiple reporting standards give US Nuclear the flexibility to control reporting costs and complexity, while still providing a premium market.

    (more…)

  • US Nuclear Corp. (PINK: UCLE) | SNN Network

    SNNLive caught up with Robert Goldstein, CEO of US Nuclear Corp. (OTC Pink: UCLE), at the Planet MicroCap Showcase 2019.

  • US Nuclear’s All-Purpose CBRN DroneRAD Up 777% in 2019

    USN Hires New COO Rick Landry

    US Nuclear’s All-Purpose CBRN DroneRAD Up 777% in 2019

    Los Angeles, CA. June 18, 2019 – In just the first two quarters of 2019, US Nuclear’s (OTC: UCLE) DroneRAD sales are up 777% overall DroneRAD sales for 2018, and based on promised new orders, may soar even higher. Due to new advances, USN drones are now outfitted with a complete CBRN package, chemical, biological, radiation, and nuclear sensing technology.

    In addition to detecting radiation, such as radioactive gamma hot-spots or airborne particulates, the DroneRAD is also outfitted with chemical detectors and bacterial/viral collection filters. A proprietary quick-release connector on the DroneRAD allows the operator to quickly change between sensor packages to eliminate downtime, and a special air sampling system allows the chemicals, particulates, and microbes to be collected in-flight without being disrupted by the flight turbulence.

    End-users for the DroneRAD include first responders, border security, military, homeland defense, NATO military, waste disposal, oil and gas, chemical plants, nuclear power plants, and many more.

    Chemical Detection: The DroneRAD supports multiple chemical sensors at once, and includes the following list: VOC, Carbon Dioxide, Ammonia, Carbon Monoxide, Chlorine, Formaldehyde, Hydrogen, Hydrogen Sulfide, Hydrogen Cyanide, Nitric Oxide, Nitrogen Dioxide, Oxygen, Sulfur Dioxide, Methane, and more.

    Biological/Viral Collection: Utilizing special viral and bacterial filters, the DroneRAD collects these microbes and other matter at up to 99.99% efficiency. Postflight, the biological filters are sent to a laboratory for in-depth analysis. Microbes of interest may be anthrax, botulism, plague, staph, e-Coli, cholera, salmonella, listeria, typhus, and others.

    GPS and Mapping: All measurable data, such as chemical or radioactive concentration, is GPS tagged and logged/wirelessly sent back to the operator for real-time display. The data is overlaid on Google Earth Maps in real-time, so the operator can immediately see a color-coded visual map of where and when the drone flew, and what the concentration is at each point.

    Safe Harbor Act

    This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

    Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the company’s website at http://www.usnuclearcorp.com

    CONTACT:

    US Nuclear Corp. (UCLE)
    Robert I. Goldstein, President, CEO, and Chairman
    Rachel Boulds, Chief Financial Officer
    (818) 883 7043
    Email: info@usnuclearcorp.com

  • US Nuclear Signs Agreement to Acquire an Interest in a Leading Fusion Power Developer

    US Nuclear Signs Agreement to Acquire an Interest in a Leading Fusion Power Developer

    US Nuclear Signs Agreement to Acquire an Interest in a Leading Fusion Power Developer & Rights to Manufacture & Sell Fusion Power Generators for Electric Power Grid

    Los Angeles, CA.  April 23, 2019 – US Nuclear Corp. (OTC-UCLE) and Magneto-Inertial Fusion Technologies, Inc. (MIFTI) have now signed an agreement which grants US Nuclear 500,000 shares of Magneto-Inertial Fusion Technologies, Inc. (MIFTI) stock, the option to acquire up to 10% (ten percent) of MIFTI, and non-exclusive worldwide rights to manufacture and sell MIFTI’s patented thermonuclear fusion power generator. MIFTI’s fusion power generator can produce clean, baseload electric power for the US and other power grids and wherever small modular electric power sources are needed. The worldwide energy market is estimated to reach $6 trillion by 2030.

    Last year, US Nuclear signed a similar agreement with MIFTEC Labs for a revolutionary new way to produce medical radioisotopes from nuclear fusion power that has several cost and safety advantages over the current nuclear fission-based methods.

    (more…)

  • Oakland and Downey Demos – US Nuclear Corp

    Oakland and Downey Demos

    Oakland and Downey, California Demos

    US Nuclear Corp and UAV partner FlyCam UAV were invited to participate in two demonstrations for their UAV mounted Radiation Detection system, the DroneRAD.

    Read More

  • Oakland and Downey Demos – US Nuclear Corp

    Oakland and Downey Demos

    Oakland and Downey, California Demos

    US Nuclear Corp and UAV partner FlyCam UAV were invited to participate in two demonstrations for their UAV mounted Radiation Detection system, the DroneRAD.

    Read More

  • Good News for Drinking Water – US Nuclear Corp

    Good News for Drinking Water

    Independent Test Lab Evaluates Instrumentation for Detecting Radiation in Drinking Water

    Since 9/11 and there are still holes in the security of the nation’s infrastructure, particularly for drinking water.  This security deficit is currently being addressed in some community water systems with water monitoring instruments.

    Read More

  • The Desperate Need For Medical Isotopes

    The Desperate Need For Medical Isotopes

    The Desperate Need For Medical Isotopes

    Los Angeles, CA. March 18, 2019 – With preparations underway for manufacturing the MIFTEC Z-pinch (ZEBRA) Fusion Medical Isotope Generators, US Nuclear Corp. (OTCBB: UCLE) is one step closer to ending the dire worldwide shortage of medical isotopes.  The federal government is so desperate to find a domestic, stable supply of medical isotopes that they recently awarded over $60 million in funding to 8 projects/companies working on solutions for this demand.  Of these 8 companies, only 3 have timelines to supply medical isotopes in the near future, and of those 3, Magneto-Inertial Fusion Technologies, Inc (MIFTI, parent company to MIFTEC) has the most promising solution.  MIFTEC’s patented fusion-powered medical isotope generator can not only solve the medical isotope shortage, but the revolutionary process also offers numerous advantages to current production methods, including:

    • MIFTEC’s process is fueled by a simple isotope of hydrogen from a renewable source: seawater.
      Current production methods of medical isotopes are fission-based nuclear reactors or accelerators that require either highly enriched or low enriched uranium (HEU/LEU) to operate. These methods are costly, multi-step processes that result in nuclear waste byproducts that must be safely contained and stored for hundreds of years while being protected from theft by terrorists.
    • Due to the eco-friendly, fusion-based technology, the capital and operational costs are a fraction of that for fission or accelerator technology.  Additionally, medical isotope production costs are up to 50% less than all other current manufacturing processes.
    • The device is designed to fit into most hospitals, nuclear medicine clinics, and laboratories.  It is ideal for local, domestic production, and results in a major reduction in transportation and import costs.  Local production also solves the timeline issues of Mo-99’s 66-hour half-life.
    • No production limit problem.  Current methods to build a nuclear reactor or accelerator are time-consuming and expensive, and once finally built, these facilities have a maximum production limit.  There is currently around a $5 billion shortfall in medical isotope production. US Nuclear can build MIFTEC’s medical isotope generators in a fraction of the time and cost, with the production line continuing until demand has been filled.

    Safe Harbor Act

    This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

    Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the company’s website at http://www.usnuclearcorp.com

    CONTACT:

    US Nuclear Corp. (UCLE)
    Robert I. Goldstein, President, CEO, and Chairman
    Rachel Boulds, Chief Financial Officer
    (818) 883 7043
    Email: info@usnuclearcorp.com

    Yahoo Finance

  • Carbon 14 Major Power Industry Pollutant

    Environmental scientists have identified Carbon 14, better known as C14, as a major radiological pollutant and a serious health hazard. Emitted from both coal-fired and nuclear power plants these contaminants have only recently been identified as a major cause of radiation exposure to the general public in proximity to these power plants.  Additionally, some hospitals, universities, and pharmacology companies also emit these radionuclides.

    Read More